✨ 6 results found - Searched 21219 records in 3ms.
Tesis
Hubungan antara Rasio Neutrofil Limfosit, Rasio Limfosit Monosit dan Tumor Associated Macrophage terhadap Progression Free Survival 1 tahun pasien kanker payudara stadium lanjut baru HR-Positif Her2-Negatif
2024 | BY SUKAMTO - Tantri Hellyanti - Wulyo Rajapto - M. Arman Nasution- Relationship between Neutrophil Lymphocyte Ratio, Lymphocyte Monocyte Ratio and Tumor Associated Macrophage to 1 -year Progression Free Survival of patients with de novo advanced breast cancer patients HR-Positive Her2- Negative.
- Nomor Panggil T24442fk
Tesis
Pengaruh Elektroakupunktur Terhadap Jumlah Persentase Limfosit Sediaan Apus Darah Tepi Pada Mencit C3H Model Adenokarsinoma Payudara
2017 | BY Rizki Kamalia - Atikah Chalida Barasila - Adiningsih Srilestari - Hasan Mihardja- The Effect of Electroacupunture on Percentage of Lymphocyte Count of Peripheral Blood Smear In C3H Mice of Breast Adenocarcinoma Model .
- Nomor Panggil T17211fk
Skripsi
Hubungan Perubahan Status Indeks Masa Tubuh dengan Neutrophil-to-Lymphocyte Ratio pada Kanker Payudara
2018 | BY Denny Grecius Siregar - Andhika Rachman- Relationship between Body Mass Index Status Change with Neutrophil-to-Lymphocyte Ratio in Breast Cancer.
- Nomor Panggil S18007fk
Skripsi
Hubungan Metastasis Kanker Payudara Pasien Overweight/Obesitas terhadap Rasio Platelet-Limfosit
2018 | BY Alexander Kelvyn Kristianto - Andhika Rachman- Relationship between Metastasis to Platelet-to-Lymphocyte Ratio in Overweight/Obese Breast Cancer Patients.
- Nomor Panggil S18004fk
Tesis
Hubungan Neutrophil-Lymphocyte Ratio dan Platelet-Lymphocyte Ratio dengan Risiko Kanker Payudara di Rumah Sakit Cipto Mangunkusumo
2023 | BY Kenneth Gunawan - Sonar Soni Panigoro- The association of Neutrophil-Lymphocyte Ratio and PlateletLymphocyte Ratio with Breast Cancer Risk at Cipto Mangunkusumo Hospital.
- Nomor Panggil T23113fk
Tesis
Intensitas stromal tumor infiltrating lymphocytes (sTIL) dan ekspresi programmed death ligand 1 (PD-L1) sebagai prediktor respons patologis kanker payudara terhadap terapi neoadjuvan di RSCM
2022 | BY Devi Felicia - Puspita Eka Wuyung - Primariadewi Rustamadji- Stromal tumor infiltrating lymphocytes (sTIL) intensity and programmed death ligand 1 (PD-L1) expression as pathological predictors of breast cancer response to neoadjuvant therapy in RSCM.
- Nomor Panggil T22252fk